Abstract | BACKGROUND: Previous studies have showed that argonaute 2 is a potential factor related to genesis of several cancers, however, there have been no reports concerning gliomas. METHODS:
Paraffin specimens of 129 brain glioma cases were collected from a hospital affiliated to Binzhou Medical University from January 2008 to July 2013. We examined both argonaute 2 mRNA and protein expression by real-time quantitative PCR (qRT-PCR), Western blot analysis, and immunohistochemistry (IHC). The survival curves of the patients were determined using the Kaplan-Meier method and Cox regression, and the log-rank test was used for statistical evaluations. RESULTS: Both argonaute 2 mRNA and protein were upregulated in high-grade when compared to low-grade tumor tissues. Multivariate analysis revealed that argonaute 2 protein expression was independently associated with the overall survival (HR=4.587, 95% CI: 3.001-6.993; P=0.002), and that argonaute 2 protein expression and WHO grading were independent prognostic factors for progression-free survival (HR=4.792, 95% CI: 3.993-5.672; P<0.001, and HR=2.109, 95% CI: 1.278-8.229; P=0.039, respectively). Kaplan-Meier analysis with the log-rank test indicated that high argonaute 2 protein expression had a significant impact on overall survival (P=0.0169) and progression-free survival (P=0.0324). CONCLUSIONS: The present study showed that argonaute 2 expression is up-regulated in gliomas. Argonaute 2 might also serve as a novel prognostic marker.
|
Authors | Bo Feng, Peng Hu, Shu-Jun Lu, Jin-Bo Chen, Ru-Li Ge |
Journal | Asian Pacific journal of cancer prevention : APJCP
(Asian Pac J Cancer Prev)
Vol. 15
Issue 9
Pg. 4079-83
( 2014)
ISSN: 2476-762X [Electronic] Thailand |
PMID | 24935600
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- AGO2 protein, human
- Argonaute Proteins
- Biomarkers, Tumor
- RNA, Messenger
|
Topics |
- Adult
- Aged
- Argonaute Proteins
(biosynthesis)
- Biomarkers, Tumor
(genetics)
- Brain Neoplasms
(genetics, mortality, pathology)
- Disease Progression
- Disease-Free Survival
- Female
- Glioma
(genetics, mortality, pathology)
- Humans
- Immunohistochemistry
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Proportional Hazards Models
- RNA, Messenger
(genetics)
- Tissue Preservation
|